We observed that lower FAK expression significantly correlated with a progressive disease for patients with CLL (Figure 2A; p = 0.0051), while we could not find any correlations with the clinical and biological parameters for PYK2 in our cohort of patients. The gene discussed is PTK2; the disease is B-cell chronic lymphocytic leukemia.